Gordon L. Amidon

38.6k total citations · 6 hit papers
406 papers, 29.7k citations indexed

About

Gordon L. Amidon is a scholar working on Pharmaceutical Science, Oncology and Molecular Biology. According to data from OpenAlex, Gordon L. Amidon has authored 406 papers receiving a total of 29.7k indexed citations (citations by other indexed papers that have themselves been cited), including 160 papers in Pharmaceutical Science, 136 papers in Oncology and 87 papers in Molecular Biology. Recurrent topics in Gordon L. Amidon's work include Drug Solubulity and Delivery Systems (136 papers), Drug Transport and Resistance Mechanisms (113 papers) and Analytical Chemistry and Chromatography (53 papers). Gordon L. Amidon is often cited by papers focused on Drug Solubulity and Delivery Systems (136 papers), Drug Transport and Resistance Mechanisms (113 papers) and Analytical Chemistry and Chromatography (53 papers). Gordon L. Amidon collaborates with scholars based in United States, Germany and Japan. Gordon L. Amidon's co-authors include Vinod P. Shah, Hans Lennernäs, John R. Crison, Lawrence X. Yu, Arik Dahan, Jennifer Dressman, Vinod Labhasetwar, Gregory E. Amidon, Yasuhiro Tsume and David Fleisher and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

Gordon L. Amidon

404 papers receiving 28.3k citations

Hit Papers

A Theoretical Basis for a Biopharmaceutic Drug Classifica... 1995 2026 2005 2015 1995 1998 1996 2003 1997 1000 2.0k 3.0k 4.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. A Theoretical Basis for a Biopharmaceutic Drug Classification: The Correlation of in Vitro Drug Product Dissolution and in Vivo Bioavailability
    1995 4.2k citations Gordon L. Amidon, Hans Lennernäs et al. Pharmaceutical Research profile →
  2. Dissolution Testing as a Prognostic Tool for Oral Drug Absorption: Immediate Release Dosage Forms
    1998 841 citations Gordon L. Amidon, Christos Reppas et al. Pharmaceutical Research profile →
  3. Gastrointestinal Uptake of Biodegradable Microparticles: Effect of Particle Size
    1996 755 citations Gordon L. Amidon et al. Pharmaceutical Research profile →
  4. Molecular Properties of WHO Essential Drugs and Provisional Biopharmaceutical Classification
    2003 696 citations Marival Bermejo, Hans Lennernäs et al. Molecular Pharmaceutics profile →
  5. The Mechanism of Uptake of Biodegradable Microparticles in Caco-2 Cells Is Size Dependent
    1997 677 citations Elke Walter, Gordon L. Amidon et al. Pharmaceutical Research profile →
  6. Quantification of Gastrointestinal Liquid Volumes and Distribution Following a 240 mL Dose of Water in the Fasted State
    2014 367 citations Deanna M. Mudie, Gordon L. Amidon et al. Molecular Pharmaceutics profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gordon L. Amidon United States 81 13.9k 6.8k 6.3k 5.1k 4.0k 406 29.7k
Jennifer Dressman Germany 76 14.1k 1.0× 3.4k 0.5× 3.3k 0.5× 5.6k 1.1× 3.6k 0.9× 347 22.4k
Christopher J. H. Porter Australia 74 9.9k 0.7× 3.7k 0.5× 6.1k 1.0× 2.9k 0.6× 2.6k 0.7× 311 21.7k
Patrick Augustijns Belgium 73 8.8k 0.6× 3.1k 0.5× 3.5k 0.6× 4.3k 0.9× 2.2k 0.6× 409 18.3k
Vinod P. Shah United States 56 9.1k 0.7× 2.0k 0.3× 3.4k 0.5× 3.1k 0.6× 2.8k 0.7× 259 19.7k
Hans Lennernäs Sweden 62 7.6k 0.5× 5.4k 0.8× 3.2k 0.5× 2.1k 0.4× 2.2k 0.6× 269 17.4k
Per Artursson Sweden 84 6.4k 0.5× 7.5k 1.1× 8.2k 1.3× 1.3k 0.2× 2.3k 0.6× 263 23.5k
William N. Charman Australia 60 7.4k 0.5× 2.6k 0.4× 3.6k 0.6× 1.8k 0.4× 1.5k 0.4× 170 14.8k
Marcus E. Brewster United States 56 8.7k 0.6× 1.1k 0.2× 3.7k 0.6× 3.9k 0.8× 2.6k 0.7× 209 15.8k
Þorsteinn Loftsson Iceland 65 12.6k 0.9× 758 0.1× 5.2k 0.8× 4.5k 0.9× 3.8k 1.0× 306 21.5k
Masaki Otagiri Japan 58 2.5k 0.2× 3.9k 0.6× 9.7k 1.5× 1.9k 0.4× 2.3k 0.6× 601 18.7k

Countries citing papers authored by Gordon L. Amidon

Since Specialization
Citations

This map shows the geographic impact of Gordon L. Amidon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gordon L. Amidon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gordon L. Amidon more than expected).

Fields of papers citing papers by Gordon L. Amidon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gordon L. Amidon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gordon L. Amidon. The network helps show where Gordon L. Amidon may publish in the future.

Co-authorship network of co-authors of Gordon L. Amidon

This figure shows the co-authorship network connecting the top 25 collaborators of Gordon L. Amidon. A scholar is included among the top collaborators of Gordon L. Amidon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gordon L. Amidon. Gordon L. Amidon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Al-Gousous, Jozef, et al.. (2024). Solubility vs Dissolution in Physiological Bicarbonate Buffer. Pharmaceutical Research. 41(5). 937–945. 8 indexed citations
2.
Salehi, Niloufar, Jozef Al-Gousous, Bart Hens, et al.. (2024). Comparative Evaluation of Dissolution Performance in a USP 2 Setup and Alternative Stirrers and Vessel Designs: A Systematic Computational Investigation. Molecular Pharmaceutics. 21(5). 2406–2414. 1 indexed citations
3.
Marković, Milica, Moran Zur, Daniel Porat, et al.. (2022). The Role of Paracellular Transport in the Intestinal Absorption and Biopharmaceutical Characterization of Minoxidil. Pharmaceutics. 14(7). 1360–1360. 9 indexed citations
4.
Augustijns, Patrick, Maria Vertzoni, Christos Reppas, et al.. (2020). Unraveling the behavior of oral drug products inside the human gastrointestinal tract using the aspiration technique: History, methodology and applications. European Journal of Pharmaceutical Sciences. 155. 105517–105517. 22 indexed citations
5.
Bhatt‐Mehta, Varsha, et al.. (2020). A proposed pediatric biopharmaceutical classification system for medications for chronic diseases in children. European Journal of Pharmaceutical Sciences. 152. 105437–105437. 10 indexed citations
6.
Tsume, Yasuhiro, et al.. (2019). The in vivo predictive dissolution for immediate release dosage of donepezil and danazol, BCS class IIc drugs, with the GIS and the USP II with biphasic dissolution apparatus. Journal of Drug Delivery Science and Technology. 56. 100920–100920. 18 indexed citations
7.
Bermejo, Marival, Gislaine Kuminek, Jozef Al-Gousous, et al.. (2019). Exploring Bioequivalence of Dexketoprofen Trometamol Drug Products with the Gastrointestinal Simulator (GIS) and Precipitation Pathways Analyses. Pharmaceutics. 11(3). 122–122. 15 indexed citations
8.
Al-Gousous, Jozef, Daniel P. McNamara, Bart Hens, et al.. (2018). Mass Transport Analysis of the Enhanced Buffer Capacity of the Bicarbonate–CO2 Buffer in a Phase-Heterogenous System: Physiological and Pharmaceutical Significance. Molecular Pharmaceutics. 15(11). 5291–5301. 32 indexed citations
9.
Talattof, Arjang & Gordon L. Amidon. (2018). Pulse Packet Stochastic Model for Gastric Emptying in the Fasted State: A Physiological Approach. Molecular Pharmaceutics. 15(6). 2107–2115. 12 indexed citations
10.
Xu, Hao, et al.. (2017). Improved Protease-Targeting and Biopharmaceutical Properties of Novel Prodrugs of Ganciclovir. Molecular Pharmaceutics. 15(2). 410–419. 5 indexed citations
11.
Tsume, Yasuhiro, Kazuki Matsui, Susumu Takeuchi, et al.. (2017). The impact of supersaturation level for oral absorption of BCS class IIb drugs, dipyridamole and ketoconazole, using in vivo predictive dissolution system: Gastrointestinal Simulator (GIS). European Journal of Pharmaceutical Sciences. 102. 126–139. 42 indexed citations
12.
Koenigsknecht, Mark J., Jason Baker, Bo Wen, et al.. (2017). In Vivo Dissolution and Systemic Absorption of Immediate Release Ibuprofen in Human Gastrointestinal Tract under Fed and Fasted Conditions. Molecular Pharmaceutics. 14(12). 4295–4304. 45 indexed citations
13.
Mudie, Deanna M., et al.. (2012). Mechanistic analysis of solute transport in an in vitro physiological two‐phase dissolution apparatus. Biopharmaceutics & Drug Disposition. 33(7). 378–402. 73 indexed citations
14.
Dahan, Arik & Gordon L. Amidon. (2009). Small intestinal efflux mediated by MRP2 and BCRP shifts sulfasalazine intestinal permeability from high to low, enabling its colonic targeting. American Journal of Physiology-Gastrointestinal and Liver Physiology. 297(2). G371–G377. 94 indexed citations
15.
Dahan, Arik & Gordon L. Amidon. (2009). MRP2 mediated drug–drug interaction: Indomethacin increases sulfasalazine absorption in the small intestine, potentially decreasing its colonic targeting. International Journal of Pharmaceutics. 386(1-2). 216–220. 51 indexed citations
16.
Walter, Elke, et al.. (1996). HT29-MTX/Caco-2 Cocultures as an in Vitro Model for the Intestinal Epithelium: In Vitro–in Vivo Correlation with Permeability Data from Rats and Humans. Journal of Pharmaceutical Sciences. 85(10). 1070–1076. 222 indexed citations
17.
Mosberg, Henry I., et al.. (1991). Structural Requirements for the Intestinal Mucosal-Cell Peptide Transporter: The Need for N-Terminal α-Amino Group. Pharmaceutical Research. 8(5). 593–599. 41 indexed citations
18.
19.
Donovan, Maureen D., Gordon L. Flynn, & Gordon L. Amidon. (1990). Absorption of Polyethylene Glycols 600 Through 2000: The Molecular Weight Dependence of Gastrointestinal and Nasal Absorption. Pharmaceutical Research. 7(8). 863–868. 155 indexed citations
20.
Donovan, Maureen D., et al.. (1990). The Molecular Weight Dependence of Nasal Absorption: The Effect of Absorption Enhancers. Pharmaceutical Research. 7(8). 808–815. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jennifer Dressman Breakdown of academic impact, for papers by Christopher J. H. Porter Breakdown of academic impact, for papers by Patrick Augustijns Breakdown of academic impact, for papers by Vinod P. Shah Breakdown of academic impact, for papers by Hans Lennernäs Breakdown of academic impact, for papers by Per Artursson Breakdown of academic impact, for papers by William N. Charman Breakdown of academic impact, for papers by Marcus E. Brewster Breakdown of academic impact, for papers by Þorsteinn Loftsson Breakdown of academic impact, for papers by Masaki Otagiri
Rankless by CCL
2026